Potential Source of Stem Cells

Research in a mouse model identified a source of stem cells in the meninges.

In this Medical News Minute, developed exclusively for Neurology Times, Dr. Bobby Lazzara discusses a study in a mouse model that identified a source of stem cells in the meninges. The cells migrated from the meninges to the cortex in the neonatal brain and differentiated into functional cortical neurons.

Related Videos
Related Content

Efgartigimod Effective Across Subgroups, FDA to Hold AdComm Meeting on SRP-9001, Reboxetine Demonstrates Positive Effect on Obstructive Sleep Apnea

March 25th 2023

Episode 85: Impact of Narcolepsy on Social Relationship Health in Adolescents

March 24th 2023

Depression History Shows No Impact on Efficacy, Safety of Solriamfetol in Treating Obstructive Sleep Apnea, Narcolepsy

March 24th 2023

Special Episode: Trofinetide Approved for Rett Syndrome

March 13th 2023

Myasthenia Agent Zilucoplan Continues to Show Positive Efficacy in Long-Term Extension

March 23rd 2023

Consensus Considerations Developed for SRP-9001 Adverse Event Management in DMD

March 23rd 2023

Efgartigimod Effective Across Subgroups, FDA to Hold AdComm Meeting on SRP-9001, Reboxetine Demonstrates Positive Effect on Obstructive Sleep Apnea

March 25th 2023

Episode 85: Impact of Narcolepsy on Social Relationship Health in Adolescents

March 24th 2023

Depression History Shows No Impact on Efficacy, Safety of Solriamfetol in Treating Obstructive Sleep Apnea, Narcolepsy

March 24th 2023

Special Episode: Trofinetide Approved for Rett Syndrome

March 13th 2023

Myasthenia Agent Zilucoplan Continues to Show Positive Efficacy in Long-Term Extension

March 23rd 2023

Consensus Considerations Developed for SRP-9001 Adverse Event Management in DMD

March 23rd 2023

Efgartigimod Effective Across Subgroups, FDA to Hold AdComm Meeting on SRP-9001, Reboxetine Demonstrates Positive Effect on Obstructive Sleep Apnea

March 25th 2023

Episode 85: Impact of Narcolepsy on Social Relationship Health in Adolescents

March 24th 2023

Depression History Shows No Impact on Efficacy, Safety of Solriamfetol in Treating Obstructive Sleep Apnea, Narcolepsy

March 24th 2023

Special Episode: Trofinetide Approved for Rett Syndrome

March 13th 2023

Myasthenia Agent Zilucoplan Continues to Show Positive Efficacy in Long-Term Extension

March 23rd 2023

Consensus Considerations Developed for SRP-9001 Adverse Event Management in DMD

March 23rd 2023
© 2023 MJH Life Sciences

All rights reserved.